Mont. Admin. r. 24.174.505 - PHARMACIST PRESCRIBING: GENERAL REQUIREMENTS
(1) Pursuant to [SB 112 (1), L. 2023] and
these rules, any pharmacist may independently prescribe.
(2) The pharmacist prescribing under this
rule must obtain adequate information about the patient's health status to make
appropriate decisions based on the applicable standard of care and the best
available evidence. For each drug or device the pharmacist intends to
prescribe, the pharmacist must maintain a patient assessment based on current
clinical guidelines, best practice standards, or evidence-based research
findings, as applicable.
(3) The
pharmacist must document an appropriate follow-up care plan, including any
monitoring parameters, as indicated by the patient assessment.
(4) The pharmacist must inquire about the
identity of the patient's primary care provider or provider of record. If a
provider is identified, the pharmacist must document the information and notify
the provider at the earliest reasonable time following the prescribing of a
drug or device.
(5) The pharmacist
must maintain documentation adequate to justify the care provided, including,
but not limited to the information collected as part of the patient assessment,
the prescription record, any notification provided as required under this rule,
and the follow-up care plan. Records must be made available for inspection by
the board.
Notes
AUTH: 37-7-201, MCA; IMP: [Senate Bill 112 (2023)]
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.